Highlights
![Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617](https://marketing.webassets.siemens-healthineers.com/8f96e15b57e623b0/921f67b11ff7/v/dcaa135a2ea5/siemens-healthineers_mi_theranostics_177-lu-psma_prostate-cancer_Cornell_hero.jpg)
Case study: Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617
This clinical case demonstrates how Symbia Intevo Bold™ with xSPECT Quant™ enables 177Lu-PSMA-617 treatment response assessment.
![Empowering precision oncology: Expanding access to next-generation theranostics](https://marketing.webassets.siemens-healthineers.com/58b9dcb53d717844/312f3669b08f/v/e467fee74ebe/siemens-healthineers_mi_clinical-corner_snmmi-2023_next-generation_theranostics.jpg)
Scientific presentation:
Empowering precision oncology - Expanding access to next-generation theranostics
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.
![Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via](https://marketing.webassets.siemens-healthineers.com/2329546de53f6214/edb43cc4dc8b/v/d2624737efae/siemens-healthineers_mi_clinical-corner_video-spect-ct-reading-experience.jpg)
Scientific presentation: Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via
Iain Duncan, MD, Garran Medical Imaging, Canberra, Australia
![Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617](https://marketing.webassets.siemens-healthineers.com/8f96e15b57e623b0/921f67b11ff7/v/dcaa135a2ea5/siemens-healthineers_mi_theranostics_177-lu-psma_prostate-cancer_Cornell_hero.jpg)
Case study: Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617
This clinical case demonstrates how Symbia Intevo Bold™ with xSPECT Quant™ enables 177Lu-PSMA-617 treatment response assessment.
![Empowering precision oncology: Expanding access to next-generation theranostics](https://marketing.webassets.siemens-healthineers.com/58b9dcb53d717844/312f3669b08f/v/e467fee74ebe/siemens-healthineers_mi_clinical-corner_snmmi-2023_next-generation_theranostics.jpg)
Scientific presentation:
Empowering precision oncology - Expanding access to next-generation theranostics
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.
![Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via](https://marketing.webassets.siemens-healthineers.com/2329546de53f6214/edb43cc4dc8b/v/d2624737efae/siemens-healthineers_mi_clinical-corner_video-spect-ct-reading-experience.jpg)
Scientific presentation: Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via
Iain Duncan, MD, Garran Medical Imaging, Canberra, Australia
![Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617](https://marketing.webassets.siemens-healthineers.com/8f96e15b57e623b0/921f67b11ff7/v/dcaa135a2ea5/siemens-healthineers_mi_theranostics_177-lu-psma_prostate-cancer_Cornell_hero.jpg)
Case study: Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617
This clinical case demonstrates how Symbia Intevo Bold™ with xSPECT Quant™ enables 177Lu-PSMA-617 treatment response assessment.
![Empowering precision oncology: Expanding access to next-generation theranostics](https://marketing.webassets.siemens-healthineers.com/58b9dcb53d717844/312f3669b08f/v/e467fee74ebe/siemens-healthineers_mi_clinical-corner_snmmi-2023_next-generation_theranostics.jpg)
![Clinical experience of routine SPECT/CT reading after migrating from Symbia.net to syngo.via](https://marketing.webassets.siemens-healthineers.com/2329546de53f6214/edb43cc4dc8b/v/d2624737efae/siemens-healthineers_mi_clinical-corner_video-spect-ct-reading-experience.jpg)
![Fast, quantitative SPECT/CT acquisition following multiple therapy cycles of 177Lu-PSMA-617](https://marketing.webassets.siemens-healthineers.com/8f96e15b57e623b0/921f67b11ff7/v/dcaa135a2ea5/siemens-healthineers_mi_theranostics_177-lu-psma_prostate-cancer_Cornell_hero.jpg)